At 7.3 years’ median follow-up, cabazitaxel failed to improve clinical PFS (62.8% vs 67.2%), metastasis-free survival, or overall survival versus androgen deprivation therapy plus radiotherapy.

Adding hormone therapy to postoperative radiotherapy did not improve OS for most patients ...

A “search and destroy” treatment has been found to halt tumours in some men with incurable prostate cancer. The early-stage ...

The assay is designed to encourage informed patient-physician decision-making when choosing a treatment option in localised ...

A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to postoperative radiotherapy may provide little survival benefit for most men ...

A new study published in the journal of BMC Surgery revealed postoperative radiotherapy, alone or with drug injections, greatly lowers keloid recurrence when compared to surgery alone, and ...

Rochester Regional Health has installed a new adaptive radiation therapy system at Rochester General Hospital, expanding its cancer treatment capabilities. The health system announced Wednesday that ...

Ultrahypofractionated radiotherapy yields non-inferior 10-year survival outcomes compared to conventional treatment in ...

A team of researchers from the Andalusian Centre for Molecular Biology and Regenerative Medicine (CABIMER) and the University ...

The combination of stereotactic RT or radiosurgery with immunotherapy or targeted therapy shows manageable toxicity and improved local control and clinical benefit in patients with brain metastases.

Extramedullary haematopoiesis (EMH) is a clinical manifestation of myelofibrosis (MF), which can lead to significant localised symptoms. A patient in her 70s with a history of MF presented with a ...